Functional Characterization Experiment summary for ENCSR913DHP
doi:10.17989/ENCSR913DHP
Summary
- Status
- released
- Assay
- Flow-FISH CRISPR screen
- Biosample summary
- Homo sapiens K562 genetically modified (insertion) using transduction, using CRISPRi (sgRNA) for chr8:126736096-128735246
- Biosample Type
- cell line
- Perturbation type
- CRISPRi
- Tiling modality
- full tiling
- Examined loci
- PVT1 (90-100%)
- CRISPR screen readout
- HCR-FlowFISH
- Replication type
- isogenic
- Description
- PVT1
- Treatments
- 1 μg/mL doxycycline (CHEBI:50845) for 48 hours
- Nucleic acid type
- DNA
- Platform
- Illumina MiSeq, Illumina NextSeq 500
- Controls
- Elements references
- ENCSR414XQE (GRCh38 chr8:126736096-128735246)
- Elements cloning
- ENCSR782RDD
Attribution
ENCODE4 project
- Lab
- Pardis Sabeti, Broad
- Award
- UM1HG009435 (Pardis Sabeti, Broad)
- Project
- ENCODE
- Aliases
- pardis-sabeti:PVT1_HS_exp
- Date submitted
- December 4, 2020
- Date released
- May 20, 2021
- Functional Characterization Series
- ENCSR496MZF
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Library |
---|---|---|---|---|---|
2 | 1 | Homo sapiens K562 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRi (sgRNA) treated with 1 μg/mL doxycycline for 48 hours | ENCBS610KAT | ENCGM097HOE, ENCGM470LXQ | ENCLB645MMC |
1 | 1 | Homo sapiens K562 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRi (sgRNA) treated with 1 μg/mL doxycycline for 48 hours | ENCBS784LES | ENCGM097HOE, ENCGM470LXQ | ENCLB719XGQ |